Dan Cotoia
Senior Director, Corporate Planning & Strategy Finance at Eisai US
- Role
- Sr Director, Corporate Planning & Strategy Finance at Eisai Us at Eisai US
- Location
- Morris Plains, NJ, US
- LinkedIn followers
- 500 followers
About Dan Cotoia
Strategic Finance Executive with international and domestic pharmaceutical healthcare experience at leading firms: Eisai, Bayer Healthcare, GSK, and J&J. Brings unique blend of strategic thinking, technical financial & accounting acumen, and people management strengths, critical to advancing overall company vision & mission. MBA - Rutgers UniversityWharton FP & A Certification Recipient: Successful completion of Wharton\'s Spring 2024 inaugural FP & A certification program Senior Director Corporate Planning & Strategy Finance, responsible for US Neurology - Alzheimer\'s Disease, US Oncology, US Market Access, & US Indirect Field Force at Eisai US. Global & International Finance, Finance Business Partnering, Alliance Finance Collaborations, US Commercial Finance, Driving Partnerships, Corporate Strategy, Communicating for Results, Catalyst for Change, Enterprise Thinking, Strategic Decision Making, Commercial Pricing, Financial Modeling, People Development, Technical Expertise, Cost Accounting, Clinical Studies and Medical Finance
Experience
Sr Director, Corporate Planning & Strategy Finance at Eisai Us
Jul 2024 — Present · NJ, US
Provide strategic financial leadership and serve as trusted partner to combined Neurology – Alzheimer’s Disease (AD) & Oncology businesses, as well as manage total operating expenses across Neurology – AD, Oncology, US Market Access, & US Field Force. Frequently engage with Executive Leadership including US President, CFO, and EVP Commercial for business updates and progress to commitments- Appointed role expansion overseeing US Neurology – AD in 2025, inclusive of Profit Share Agreement with Biogen, scaling operational efficiencies identified in Oncology Collaboration to Neurology- Established brand allocation rate process aligned with Audit, for Market Access and Indirect Field Force, providing a detailed calculation on brand P&L allocations- Revamped Profit Share agreement reporting, resulting in capturing previously unbilled expenses, aligned with contractual language & approved by audit- Identified & implemented reduction in LCA reporting requirements, significantly reducing organizational resource commitments required for output- Completely revamped entire Market Access month-end accounting close and accrual process in compliance with IFRS/US GAAP reporting standards; identified >$500K in over-accrued items- Successfully manage a team of six FTEs, fostering frequent collaboration and process efficiencies.
Education
The College of New Jersey
Bachelors of Science, Finance
2003 — 2007
Rutgers Business School
Master of Business Administration (M.B.A.), Dual Concentration: Marketing and Leadership & Strategy
2011 — 2014
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.